Variants of tissue-type plasminogen activator that display extraordinary resistance to inhibition by the serpin plasminogen activator inhibitor type 1.

The Journal of Biological Chemistry
K Tachias, E L Madison

Abstract

Fibrinolysis is regulated in part by the interaction of tissue-type plasminogen activator (t-PA) and plasminogen activator inhibitor type 1 (PAI-1). Previous investigations suggest that three specific arginine residues, Arg-298, Arg-299, and Arg-304 of t-PA, play a critical role in this important regulatory interaction. Our earlier studies have demonstrated that conversion of any of these three residues to a glutamic acid residue reduced the rate of inhibition of t-PA by PAI-1 by factors varying from 58-64. In addition, we have reported that the second order rate constant for inhibition by PAI-1 of the variant t-PA/K296E,R298E,R299E is reduced by a factor of approximately 2800 compared with that of wild type t-PA. In this study, we have significantly extended our earlier observations by identifying t-PA variants that are substantially more resistant to inhibition by PAI-1 than any previously reported variants of t-PA or urokinase-type plasminogen activator. Single-chain t-PA/R275E,R298E, R299E,R304E, for example, is inhibited by PAI-1 approximately 120, 000 times less rapidly than single-chain, wild type t-PA. We also report the first direct comparison of the effects of charge reversal mutations of Arg-298, Arg-299, and/or Arg-...Continue Reading

References

Jan 3, 1992·The American Journal of Cardiology·D Collen
May 1, 1990·Proceedings of the National Academy of Sciences of the United States of America·E L MadisonR S Bassel-Duby
Jun 29, 1989·Nature·E L MadisonJ F Sambrook
Jan 1, 1985·Proceedings of the National Academy of Sciences of the United States of America·T A Kunkel
Sep 1, 1981·The Biochemical Journal·E Suenson, S Thorsen
Mar 8, 1984·The New England Journal of Medicine·F Van de WerfB E Sobel
Aug 1, 1983·Circulation·D Collen, M Verstraete
May 29, 1981·Biochimica Et Biophysica Acta·S ThorsenS Magnusson
Aug 4, 1995·The Journal of Biological Chemistry·K Tachias, E L Madison
Aug 15, 1995·Proceedings of the National Academy of Sciences of the United States of America·L DingE L Madison
Apr 26, 1994·Proceedings of the National Academy of Sciences of the United States of America·B A KeytJ Ogez
Sep 2, 1993·The New England Journal of Medicine·UNKNOWN GUSTO investigators
Jan 1, 1993·Methods in Enzymology·H R Lijnen, D Collen
Jan 3, 1997·The Journal of Biological Chemistry·K Tachias, E L Madison

❮ Previous
Next ❯

Citations

Mar 30, 2010·Proteome Science·Stefania AngelucciCarmine Di Ilio
Jul 5, 2013·PloS One·Carolyn GlassArchibald Perkins
Sep 27, 2013·PloS One·Daila S GridleyMichael J Pecaut
Aug 5, 2000·Biochemical and Biophysical Research Communications·P PeraniY Courtois
Jun 13, 2014·Nucleic Acid Therapeutics·Jared DamareYolanda M Fortenberry
Jun 25, 2015·Protein Science : a Publication of the Protein Society·Anna R BattTeaster Baird
Mar 16, 2004·British Journal of Haematology·Anton J G Horrevoets
Oct 27, 2007·Protein Science : a Publication of the Protein Society·Lu LiuAnne Gershenson
Nov 5, 2003·The Journal of Biological Chemistry·Catherine A IbarraJoseph D Shore
Jul 31, 2019·Computational and Structural Biotechnology Journal·Jan MicanJiri Damborsky
Jan 9, 2021·Frontiers in Cardiovascular Medicine·Machteld Sillen, Paul J Declerck
Nov 25, 2011·BMC Biochemistry·Eugene A CherniavskyVladimir M Shkumatov

❮ Previous
Next ❯

Related Concepts

Related Feeds

ASBMB Publications

The American Society for Biochemistry and Molecular Biology (ASBMB) includes the Journal of Biological Chemistry, Molecular & Cellular Proteomics, and the Journal of Lipid Research. Discover the latest research from ASBMB here.